Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2004-08-24
2011-10-25
Getzow, Scott (Department: 3762)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S046000
Reexamination Certificate
active
08046076
ABSTRACT:
A system and method for introducing one or more stimulating drugs and/or applying electrical stimulation to the brain to treat mood and/or anxiety disorders uses an implantable system control unit (SCU), specifically an implantable signal/pulse generator (IPG) or microstimulator with one or more electrodes in the case of electrical stimulation, and an implantable pump with one or more catheters in the case of drug infusion. In cases requiring both electrical and drug stimulation, one or more SCUs are used. Alternatively and preferably, when needed, an SCU provides both electrical stimulation and one or more stimulating drugs. In a preferred embodiment, the system is capable of open- and closed-loop operation. In closed-loop operation, at least one SCU includes a sensor, and the sensed condition is used to adjust stimulation parameters.
REFERENCES:
patent: 5092835 (1992-03-01), Schurig et al.
patent: 5094242 (1992-03-01), Gleason et al.
patent: 5193539 (1993-03-01), Schulman et al.
patent: 5193540 (1993-03-01), Schulman et al.
patent: 5299569 (1994-04-01), Wernicke et al.
patent: 5304367 (1994-04-01), Biegon
patent: 5312439 (1994-05-01), Loeb
patent: 5324316 (1994-06-01), Schulman et al.
patent: 5405367 (1995-04-01), Schulman et al.
patent: 5540734 (1996-07-01), Zabara
patent: 5975085 (1999-11-01), Rise
patent: 6016449 (2000-01-01), Fischell et al.
patent: 6051017 (2000-04-01), Loeb et al.
patent: 6061593 (2000-05-01), Fischell et al.
patent: 6128537 (2000-10-01), Rise
patent: 6167311 (2000-12-01), Rezai
patent: 6263237 (2001-07-01), Rise
patent: 6366813 (2002-04-01), DiLorenzo
patent: 6415184 (2002-07-01), Ishikawa et al.
patent: 6418344 (2002-07-01), Rezai et al.
patent: 6427086 (2002-07-01), Fischell et al.
patent: 6463328 (2002-10-01), John
patent: 6464687 (2002-10-01), Ishikawa et al.
patent: 6597954 (2003-07-01), Pless et al.
patent: 2001/0003799 (2001-06-01), Boveja
patent: 2002/0161403 (2002-10-01), Meadows et al.
patent: 2003/0036781 (2003-02-01), Nuttin et al.
patent: 2005/0065574 (2005-03-01), Rezai
patent: WO-87/07511 (1987-12-01), None
patent: WO-94/00188 (1994-01-01), None
patent: WO-95/21591 (1995-08-01), None
patent: WO-98/37926 (1998-09-01), None
patent: WO-98/43700 (1998-10-01), None
patent: WO-98/43701 (1998-10-01), None
patent: WO 9846128 (1998-10-01), None
patent: WO-01/60450 (2001-08-01), None
Mezey, Eva et al. “Direct Stimulation of β2-adrenergic receptors in rat anterior pituitary induces the release of adrenocorticotropin in vivo.” National Academy of Sciences. vol. 80, No. 21, [Part 1: Biological Sciences] (Nov. 1, 1983), pp. 6728-6731.
Lubar et al., “Low-resolution electromagnetic tomography (LORETA) of cerebral activity in chronic depressive disorder”, Sep. 2003, International Journal of Psychophysiology 49 (2003) pp. 175-185.
Cameron, et al., “Micromodular Implants to Provide Electrical Stimulation of Paralyzed Muscles and Limbs”, IEEE Transactions on Biomedical Engineering, 44 (9): 781-90 (Sep. 1997).
Lubar, et al., “Low-Resolution Electromagnetic Tomography (LORETA) of Cerebral Activity in Chronic Depressive Disorder”, Int J Psycholphysiol. 49(3): 175-85 (Sep. 2003).
Abercrombie, et al., “Metabolic Rate in the Right Amygdala Predicts Negative Affect in Depressed Patients”, Neuroreport, 9(14): 3301-7 (Oct. 5, 1998).
Baxter, et al., “Caudate Glucose Metabolic Rate Changes with Both Drug and Behavior Therapy for Obsessive-compulsive Disorder”, Arch Gen Psychiatry, 49:9 681-9 (Sep. 1992).
Baxter, et al., “Cerebral Glucose Metabolic Rates in Nondepressed Patients with Obsessive-Compulsive Disorder”, Am J Psychiatry, 145:12 1560-3 (Dec. 1988).
Baxter, et al., “Cerebral Metabolic Rates for Glucose in Mood Disorders. Studies with Positron Emission Tomography and Fluorodeoxyglucose F 18”, Arch Gen Psychiatry, 42:5 441-7 (May 1985).
Baxter, et al., “Reduction of Prefrontal Cortex Glucose Metabolism Common to Three Types of Depression”, Arch Gen Psychiatry, 46:3 243-50 (Mar. 1989).
Baxter, et al., “Trazodone Treatment Response in Obsessive-Compulsive Disorder—Correlated with Shifts in Glucose Metabolism in the Caudate Nuclei”, Psychopathology, 20 Suppl 1 114-22 (1987).
Baxter, L.R., “Brain Imaging as a Tool in Establishing a Theory of Brain Pathology in Obsessive Compulsive Disorder”, J Clin Psychiatry, 51 Suppl 22-5 (Feb. 1990).
Bejjani, et al., “Transient Acute Depression Induced by High-Frequency Deep Brain Stimulation”, New England Journal of Medicine, 340(19): 1476-80 (May 13, 1999).
Bench, et al., “The Anatomy of Melancholia-Focal Abnormalities of Cerebral Blood Flow in Major Depression”, Psychol Med, 22(3):607-15 (Aug. 1992).
Brody, et al., “FDG-PET Predictors of Response to Behavioral Therapy and Pharmacotherapy in Obsessive Compulsive Disorder”, Psychiatry Res, 84:1 1-6 (Nov. 9, 1998).
Davidson, et al., “Regional Brain Function, Emotion and Disorders of Emotion”, Curr Opin Neurobiol, 9(2): 228-34 (Apr. 1999).
Davis, et al., “The Amygdala: Vigilance and Emotion”, Mol Psychiatry, 13-34 (Jan. 2001).
Drevets, et al., “Subgenual Prefrontal Cortex Abnormalities in Mood Disorders”, Nature, 386(6627): 824-7 (Apr. 24, 1997).
Drevets, W.C., “Functional Neuroimaging Studies of Depression: The Anatomy of Melancholia”, Annu Rev Med , 49:341-61 (1998).
Ebmeier, et al., “Cerebral Perfusion Correlates of Depressed Mood”, Br J Psychiatry, 170:77-81 (Jan. 1997).
Galynker, et al., “Hypofrontality and Negative Symptoms in Major Depressive Disorder”, J Nucl Med 39(4):608-12 (Apr. 1998).
Joffe, et al., “Augmentation Strategies”, J Clin Psychiatry, 57 (Suppl 7): 25-31 (1996).
Kirkcaldie, et al., “Transcranial Magnetic Stimulation as Therapy for Depression and Other Disorders”, Aust N Z J Psychiatry, 31(2): 264-72 (Apr. 1997).
Klimek, et al., “Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression”, J Neurosci, 17(21): 8451-8 (Nov. 1, 1997).
Pridmore, et al., “Transcranial Magnetic Stimulation in the Treatment of Psychiatric Disorders”, Psychiatric Clin Neurosci, 53(5): 541-8 (Oct. 1999).
Rush, et al., “Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depressions: A Multicenter Study”, Biological Psychiatry, 47:276-286, (2000).
Sackheim, et al., “The Effects of Vagus Nerve Stimulation on cognitive Performance in Patients with Treatment-Resistant Depression”, Neuropsychiatry, Neuropsychology, and Behavioral Neurology, vol. 14, No. 1, 53-62 (2001).
Saxena , et al., “Neuroimaging and Frontal-Subcortical Circuitry in Obsessive-Compulsive Disorder”, Br J Psychiatry Suppl, 35 26-37 (1998).
Stockmeier, et al., “Serotonin Receptors in Suicide Victims with Major Depression”, Neuropsychopharmacology, 16(2): 162-73 (Feb. 1997).
Yavari, et al., “Decreased Raphe Unit Activity in a Rat Model of Endogenous Depression”, Brain Res., 611(1):31-6, (May 14, 1993).
Jaax Kristen N.
Whitehurst Todd K.
Boston Scientific Neuromodulation Corporation
Dietrich Joseph
Getzow Scott
Vista IP Law Group LLP
LandOfFree
Treatment of mood and/or anxiety disorders by electrical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of mood and/or anxiety disorders by electrical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of mood and/or anxiety disorders by electrical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4253680